The estimated Net Worth of Gary K Jr Kunkle is at least $842 Tisíc dollars as of 9 September 2016. Gary Kunkle owns over 5,814 units of Perrigo plc stock worth over $842,022 and over the last 11 years Gary sold PRGO stock worth over $0.
Sign up
Gary Kunkle PRGO stock SEC Form 4 insiders trading
Gary has made over 3 trades of the Perrigo plc stock since 2015, according to the Form 4 filled with the SEC. Most recently Gary exercised 5,814 units of PRGO stock worth $97,501 on 9 September 2016.
The largest trade Gary's ever made was exercising 5,814 units of Perrigo plc stock on 9 September 2016 worth over $97,501. On average, Gary trades about 1,238 units every 43 days since 2013. As of 9 September 2016 Gary still owns at least 31,501 units of Perrigo plc stock.
You can see the complete history of Gary Kunkle stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Gary Kunkle's mailing address?
Gary's mailing address filed with the SEC is C/O PERRIGO COMPANY, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.
Insiders trading at Perrigo plc
Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen a Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.
What does Perrigo plc do?
perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
What does Perrigo plc's logo look like?
Complete history of Gary Kunkle stock trades at Perrigo plc
Perrigo plc executives and stock owners
Perrigo plc executives and other stock owners filed with the SEC include:
-
Murray Kessler,
President, Chief Executive Officer, Director -
Raymond Silcock,
Chief Financial Officer, Executive Vice President -
Murray S. Kessler,
CEO, Pres & Director -
Todd Kingma,
Executive Vice President, General Counsel, Company Secretary -
James Dillard,
Executive Vice President, Chief Scientific Officer -
Svend Andersen,
Executive Vice President, President - Consumer Healthcare International -
Sharon Kochan,
Executive Vice President, President - RX Pharmaceuticals -
Raymond P. Silcock,
CFO, Principal Accounting Officer & Exec. VP -
Svend Andersen,
Exec. VP & Pres of Consumer Healthcare International -
Richard S. Sorota,
Exec. VP & Pres of Consumer Self-Care Americas -
Todd W. Kingma,
Exec. VP, Gen. Counsel & Sec. -
James E. Dillard III,
Exec. VP & Pres of Consumer Self-Care Americas -
Rolf Classon,
Independent Director -
Donal O'Connor,
Independent Director -
Jeffrey Kindler,
Independent Director -
Theodore Samuels,
Independent Director -
Geoffrey Parker,
Independent Director -
Bradley Alford,
Independent Director -
Adriana Karaboutis,
Independent Director -
Erica Mann,
Independent Director -
Bradley Joseph,
Vice President Global Investor Relations -
Katherine Doyle,
Director -
Rich Sorota,
Executive Vice President and President - Consumer Self-Care Americas -
Grainne Quinn,
Executive Vice President, Chief Medical Officer -
Ronald Janish,
Executive Vice President - Global Operations and Supply Chain, Chief Transformation Officer -
Thomas Farrington,
Executive Vice President, Chief Information Officer -
Robert Willis,
Chief Human Resource Officer, Executive Vice President -
Kyle L. Hanson,
Exec. VP, Gen. Counsel & Corp. Sec. -
Alison Ives,
Exec. VP & Chief Scientific Officer -
Eduardo Guarita Bezerra,
Exec. VP & CFO -
Mary Reilly-Brest,
Director of Global Organizational and Human Resource Devel. -
Thomas M. Farrington,
Chief Information Officer & Exec. VP -
Shannon Hukill,
Sr. Director of Technical Operations -
Ronald C. Janish,
Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain -
Patrick Lockwood Taylor,
CEO -
Paul Weninger,
EVP, Quality Operations -
James R Michaud,
EVP, Chief HR Officer -
John T Hendrickson,
EVP Global Operations & Supply -
Gary M Cohen,
Director -
John Wesolowski,
EVP, President Rx -
Michael J Jandernoa,
Director -
Judy L Brown,
Executive VP & CFO -
Laurie Brlas,
Director -
Jeffrey C Smith,
Director -
Triona Schmelter,
EVP & President CSCA -
Uwe Roehrhoff,
CEO -
Ronald Winowiecki,
CFO -
David Ball,
EVP & CBDO -
Jacqualyn A Fouse,
Director -
Ellen Randi Hoffing,
Director -
Louis Yu,
Executive VP Global Quality -
Shlomo Yanai,
Director -
Marc Coucke,
Executive VP & GM -
Michael Robert Stewart,
Sr. VP Global Human Resources -
Joseph C Papa,
President and CEO -
Gary K Jr Kunkle,
Director -
Herman Jr Morris,
Director -
Ben Zion Zilberfarb,
Director -
Ran Gottfried,
Director -
Jatin Shah,
Sr VP & Chief Scientific Offic -
Scott F Jamison,
-
David T Gibbons,
Director -
Douglas Boothe,
EVP & GM Perrigo Pharma -
Jeffrey Needham,
EVP, President CHC Americas -
Orlando D Ashford,
Director -
Alison Ives,
EVP & Chief Scientific Officer -
Kyle Hanson,
EVP & General Counsel -
Eduardo Guarita Bezerra,
EVP & Chief Financial Officer -
Albert Manzone,
Director -
Julia M Brown,
Director